+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030- Product Image
Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030- Product Image
Sale

Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015269
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Embolization Particle Market grew from USD 1.79 billion in 2024 to USD 2.00 billion in 2025. It is expected to continue growing at a CAGR of 11.10%, reaching USD 3.37 billion by 2030.

Pioneering the Future of Embolization Particle Solutions

The field of embolization particles has matured into a critical pillar of minimally invasive therapies, offering clinicians precision tools for the targeted occlusion of blood vessels. Over recent years, the convergence of advanced material science and interventional techniques has positioned these particles at the forefront of treatment modalities for a spectrum of vascular conditions. This introduction outlines the purpose of our executive summary: to distill the most impactful trends, regulatory influences and market dynamics shaping the trajectory of embolization particle solutions.

By examining transformative innovations, the implications of trade policies and the nuanced insights derived from segmentation and regional analysis, we aim to deliver a comprehensive perspective that informs strategic decision-making. Our review encompasses the practical implications for healthcare providers, device manufacturers and strategic investors. Readers will gain a clear understanding of the competitive landscape, regulatory environment and actionable pathways to capitalize on emerging opportunities in this rapidly evolving domain.

Emerging Innovations Reshaping Embolization Particle Technology

Recent developments in embolization particle technology have transcended incremental improvements to create fundamentally new treatment paradigms. Advancements in polymer chemistry have given rise to particles that can respond dynamically to physiological cues, releasing therapeutics or altering their occlusive properties in real time. Meanwhile, progress in nano-fabrication has enabled the manufacturing of particles with unprecedented uniformity and control, reducing variability in clinical outcomes.

In parallel, the integration of imaging modalities and digital platforms has enhanced procedural precision. Techniques such as three-dimensional mapping and augmented reality now guide practitioners to the precise vascular target, minimizing non-target embolization and associated complications. Sustainability has also emerged as a key driver, with a growing emphasis on biodegradable and bioresorbable materials that reduce long-term foreign body risk and simplify follow-up imaging protocols.

Collectively, these innovations are not only elevating the safety and efficacy profiles of embolization therapies but also expanding their potential applications across oncology, neurology and interventional radiology.

Assessing the Ripple Effects of 2025 US Trade Measures on Embolization Particles

The implementation of new United States tariffs in 2025 has introduced a recalibration of cost structures across the embolization particle supply chain. Raw materials, including advanced polymers and colloidal agents, have seen price adjustments that compel manufacturers to reassess sourcing strategies. Upstream suppliers are negotiating long-term contracts to buffer against volatility, while downstream producers explore alternative materials and local partnerships to maintain competitive pricing.

Regulatory bodies are also adapting to these shifts, with evolving import classifications and compliance protocols influencing product onboarding timelines. Some device innovators are accelerating domestic production capabilities to mitigate cross-border cost pressures, fostering a reconfiguration of global manufacturing footprints. As companies navigate these dynamics, strategic investments in supply chain resilience and material diversification have become critical to preserving product margins and ensuring uninterrupted delivery of embolization solutions.

This tariff environment underscores the need for agile operational frameworks capable of responding to trade policy fluctuations while sustaining the momentum of clinical innovation.

Decoding Market Dynamics Through Comprehensive Segmentation Analysis

A multifaceted segmentation framework reveals the strategic drivers that define the embolization particle landscape. When examining products by type, gelatin sponge particles continue to hold prominence due to their established clinical track record, whereas liquid embolic systems have gained momentum by offering superior penetration in certain vascular beds. Microspheres appeal to practitioners seeking precise size calibration, and polyvinyl alcohol particles remain valued for their versatility and cost-effectiveness.

Applications drive further differentiation, with hepatic oncology procedures representing a significant focus as locoregional treatments for liver tumors expand. Neurovascular interventions demand particles with specialized flow dynamics to navigate cerebral vasculature, while peripheral arterial embolization addresses critical limb ischemia. Prostate artery embolization has emerged as a non-surgical alternative for benign prostatic hyperplasia, and uterine fibroid embolization remains a cornerstone of minimally invasive gynecological care.

End users shape adoption patterns, with ambulatory surgical centers attracting cost-sensitive elective procedures, hospitals managing complex and emergency interventions, and specialty clinics focusing on niche applications that require specialized device portfolios. The choice of embolic material further refines market positioning: natural materials such as collagen and gelatin appeal for their biocompatibility and resorbable profiles, while synthetic materials like acrylic polymers and polyvinyl alcohol offer tunable mechanical properties and enhanced stability. Finally, the mode of action distinguishes permanent solutions, which provide lasting occlusion, from temporary particles designed for transient embolization, aligning with diverse clinical objectives.

This layered segmentation analysis illuminates the interplay between clinical requirements and product innovation, guiding stakeholders toward targeted strategies for portfolio development and market penetration.

Unearthing Regional Growth Drivers Across Global Markets

Regional dynamics exhibit distinct growth patterns that inform strategic market approaches. In the Americas, a mature interventional radiology infrastructure and widespread reimbursement frameworks have accelerated the adoption of advanced embolization particles. Centers of excellence in major urban hubs drive innovation, while emerging community hospitals expand access to minimally invasive therapies.

Europe, the Middle East and Africa present a heterogeneous environment where regulatory harmonization efforts and varied healthcare funding models shape market entry strategies. Western European nations lead with early adoption of cutting-edge materials, supported by robust clinical trial ecosystems. In contrast, certain Middle Eastern markets prioritize public-private partnerships to expand vascular intervention capabilities, and segments of the African healthcare landscape are advancing initiatives to address rising incidences of oncological and peripheral vascular conditions.

Asia-Pacific stands out for its rapid capacity building, fueled by government investments in healthcare infrastructure and growing patient affordability. Market leaders are forging local manufacturing alliances to meet regulatory priorities and accelerate product registration. In parallel, innovative distribution models and digital health platforms are emerging to bridge accessibility gaps in remote regions, marking Asia-Pacific as a focal point for scalable solutions and novel partnership frameworks.

Competitive Landscape Spotlight on Leading Embolization Particle Innovators

The current competitive field is characterized by a blend of established device manufacturers and agile specialist firms. Industry leaders continue to fortify their positions through diversified portfolios that span traditional gelatin and PVA particles to next-generation liquid systems. These incumbents leverage global distribution networks and strategic collaborations with academic centers to validate new technologies and facilitate clinical adoption.

At the same time, emerging players are carving out niches by focusing on ultra-high-precision microspheres and bespoke particle formulations designed for critical neurovascular and oncological indications. These challengers employ lean R&D strategies and digital prototyping to accelerate time to market, often securing early regulatory approvals in select jurisdictions before scaling globally.

Partnerships between device innovators and contract manufacturing organizations are gaining prominence, enabling rapid capacity expansion and flexibility in material sourcing. Additionally, several companies are establishing in-house analytics capabilities to monitor post-market performance in real time, feeding back data that informs iterative product enhancements and reinforces clinical confidence.

Strategic Imperatives for Capitalizing on Emerging Opportunities

Industry leaders seeking to maintain a competitive edge must embrace a series of strategic imperatives. First, sustained investment in material science is crucial to unlocking next-generation embolization solutions that offer dynamic functionality and improved safety profiles. Equally important is the formation of cross-sector alliances, combining clinical expertise with advanced manufacturing and digital health capabilities to deliver integrated therapy platforms.

Given the evolving trade landscape, companies should diversify their material supply chains and consider establishing regional manufacturing hubs to mitigate tariff risks and optimize logistics. Engaging with regulatory agencies early in the development process will streamline approvals and reduce time to market, particularly for novel particle compositions and delivery systems.

Finally, stakeholders should prioritize data-driven decision-making by implementing robust post-market surveillance frameworks and leveraging real-world evidence to demonstrate value to payers and providers. By aligning these strategic imperatives with a clear understanding of market segmentation and regional nuances, organizations can chart a path to sustainable growth and clinical leadership.

Robust Research Framework Underpinning Comprehensive Market Insights

Our analysis draws upon a rigorous research methodology designed to ensure the highest level of reliability and relevance. A systematic review of industry literature and regulatory filings established the foundational context, while qualitative interviews with key opinion leaders and procurement specialists provided nuanced perspectives on clinical and purchasing behaviors.

Quantitative data were collected through structured surveys across a spectrum of stakeholders, encompassing device manufacturers, healthcare providers and distribution partners. Triangulation of these inputs, coupled with historical trend analysis, enabled validation of emerging patterns and the identification of potential inflection points in technology adoption.

Throughout the process, findings underwent multiple rounds of internal peer review and external expert validation, ensuring that insights reflect both current practice standards and anticipated shifts in the embolization particle ecosystem.

Charting the Path Forward in Embolization Particle Innovation

The intersection of advanced material development, regulatory evolution and shifting global trade policies has created a pivotal moment for embolization particle technologies. As clinicians increasingly demand tailored therapies with predictable performance, the market is poised to reward solutions that marry clinical efficacy with operational resilience. Success will hinge on the ability to navigate complex segmentation landscapes, adapt to regional imperatives and harness data intelligence to refine product strategies.

By prioritizing collaboration across the healthcare value chain and maintaining a forward-looking stance on materials research, industry stakeholders can unlock new avenues for patient benefit and commercial growth. The insights presented herein form a strategic compass, guiding decision-makers toward informed investments and meaningful innovations that define the next era of vascular intervention.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Gelatin Sponge Particles
    • Liquid Embolic Systems
    • Microspheres
    • Polyvinyl Alcohol Particles
  • Application
    • Hepatic Oncology
    • Neurovascular Procedures
    • Peripheral Arterial Embolization
    • Prostate Artery Embolization
    • Uterine Fibroid Embolization
  • End Use
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Embolic Material
    • Natural Materials
      • Collagen
      • Gelatin
    • Synthetic Materials
      • Acrylic Polymers
      • Polyvinyl Alcohol
  • Mode Of Action
    • Permanent
    • Temporary
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Sirtex Medical Limited
  • Guerbet Group SA
  • AngioDynamics, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Embolization Particle Market, by Product Type
8.1. Introduction
8.2. Gelatin Sponge Particles
8.3. Liquid Embolic Systems
8.4. Microspheres
8.5. Polyvinyl Alcohol Particles
9. Embolization Particle Market, by Application
9.1. Introduction
9.2. Hepatic Oncology
9.3. Neurovascular Procedures
9.4. Peripheral Arterial Embolization
9.5. Prostate Artery Embolization
9.6. Uterine Fibroid Embolization
10. Embolization Particle Market, by End Use
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Embolization Particle Market, by Embolic Material
11.1. Introduction
11.2. Natural Materials
11.2.1. Collagen
11.2.2. Gelatin
11.3. Synthetic Materials
11.3.1. Acrylic Polymers
11.3.2. Polyvinyl Alcohol
12. Embolization Particle Market, by Mode of Action
12.1. Introduction
12.2. Permanent
12.3. Temporary
13. Americas Embolization Particle Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Embolization Particle Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Embolization Particle Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Boston Scientific Corporation
16.3.2. Terumo Corporation
16.3.3. Merit Medical Systems, Inc.
16.3.4. Sirtex Medical Limited
16.3.5. Guerbet Group SA
16.3.6. AngioDynamics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EMBOLIZATION PARTICLE MARKET MULTI-CURRENCY
FIGURE 2. EMBOLIZATION PARTICLE MARKET MULTI-LANGUAGE
FIGURE 3. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 52. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 53. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 54. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 55. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 97. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 99. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 103. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 104. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 113. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 116. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 117. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 118. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 119. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 120. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 124. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 148. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 162. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 165. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 166. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 167. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 168. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 173. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 190. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 197. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 202. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 215. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 218. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 221. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 222. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 223. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 224. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 240. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 243. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 244. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 245. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 246. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 247. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 250. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 251. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 252. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 253. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 254. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 258. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 282. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 286. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 324. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 325. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Embolization Particle market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Sirtex Medical Limited
  • Guerbet Group SA
  • AngioDynamics, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.37 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030 - Product Image

Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Vascular Embolization Market Report 2025 - Product Image

Vascular Embolization Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • 53 Pages
  • Global
From
Detachable Coil Embolization System Market by End User, Delivery Mechanism, Configuration, Application, Coil Type - Global Forecast to 2030 - Product Image

Detachable Coil Embolization System Market by End User, Delivery Mechanism, Configuration, Application, Coil Type - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Uterine Fibroid Embolization Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Uterine Fibroid Embolization Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 77 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.